Where AI, Plants and Humans Connect
Scientifically validated nutraceuticals and medical foods, built on plant-derived nanovesicles and pharmaceutical-grade AI discovery.
Flori Science combines proprietary AI discovery and pharmaceutical-grade validation to systematically identify plant bioactives and nanovesicles with superior bioavailability and efficacy.
By translating stem cell and exosome biology expertise into targeted formulations, we develop evidence-based nutraceuticals and medical foods that inhibit inflammation and cellular aging while promoting regeneration and mitochondrial function.
This biology-informed approach establishes a new standard where cutting-edge science meets precision nutrition for health and longevity.
Nutraceutical development faces persistent challenges in efficacy, safety, and delivery.
Many nutraceuticals lack rigorous scientific evidence to support efficacy claims.
Challenges ensuring product purity, potency, and consistency across batches.
Inconsistent global regulations lead to varying product quality and standards.
Industry bioavailability of 5–20% leaves most active compounds unabsorbed.
Naturally plant-derived nanovesicles (pDENs) carry diverse beneficial compounds and serve as versatile delivery vehicles for bioactive agents.
Their unique cross-kingdom biological homology with human cells enables efficient internalization, superior bioavailability, and multi-target action — without artificial additives or synthetic carriers.
Carry diverse bioactive compounds including lipids, proteins, nucleic acids, and small molecules.
Naturally recognized by human cells due to cross-kingdom structural homology.
Cross biological barriers including the blood-brain barrier and intestinal epithelium.
Cost-effective, environmentally sustainable manufacturing at commercial scale.
DeePlant — our proprietary AI tool — integrates hundreds of plant sources with human biology to identify compatible and effective therapeutic applications.
Every candidate identified by AI is then validated in proprietary human cell models before any investment in clinical application. This rigorous pipeline is what distinguishes Flori Science from the nutraceutical industry at large.
Integrates hundreds of plant sources with human biology to identify compatible and effective therapeutic applications at unprecedented speed.
Proprietary 2D and 3D human cell and disease models validate AI predictions and bridge stem cell data to plant biology.
Advanced isolation and profiling from plant and mushroom-derived sources, mapping molecular cargo and biological activity.
Scalable manufacturing and regulatory pathways for nutraceuticals, medical foods and cosmeceuticals.
Plant-derived bioactives show structural and functional similarities to human molecules, enabling cross-kingdom pathway regulation.
Our extraction process maps molecular cargo and biological activity from plant and mushroom-derived sources, producing formulations optimized for stability, efficacy, and both oral and topical delivery.
Unlike single-compound nutraceuticals, pDENs carry diverse bioactive cargo that acts on multiple interconnected hallmarks of biological aging simultaneously.
This multi-target approach — validated in human cell and disease models — is what distinguishes Flori Science formulations from anything else available in the nutraceutical market.
Elimination of senescent cells via senolytics — modulating pathways that trigger cell cycle arrest.
Inhibiting chronic inflammation by downregulating pro-inflammatory cytokines.
Biogenesis support — increasing ATP synthesis and enhancing metabolic efficiency.
Support stem cell function and inhibit their aging to preserve regenerative capacity.
Antioxidant delivery — delivering enzymes and upregulating endogenous defense systems to inhibit oxidative stress.
All formulations use GRAS-classified ingredients, enabling accelerated regulatory pathways and faster market entry through FDA-compliant tracks.
60–85% bioavailability without artificial stabilizers or synthetic carriers — achieved through nature's own endosomal delivery pathway.
Cost-effective, environmentally sustainable production processes designed for commercial volumes without compromising pharmaceutical-grade quality controls.
Lead indications: Anti-aging, sarcopenia and muscle injury recovery
Targeting cellular senescence, inflammaging and mitochondrial dysfunction. Validated in human skeletal muscle cell models with superior results versus traditional nutraceuticals.
Applications: Advanced skin repair and cellular rejuvenation
Validation complete. pDEN delivery enables superior compound penetration and regenerative action for anti-aging and wound healing applications.
Lead indications: Neuronutrient support and cognitive function
pDENs confirmed to cross the blood-brain barrier and internalize in human microglia cells, reducing neuroinflammation markers in validated models.
Lead indications: Microbiome modulation and GI medical foods
Intestinal epithelial cell models demonstrate superior reduction of TNF-α secretion versus traditional anti-inflammatory phytochemicals.
Three products entering production Q3 2026 — each backed by validated human cell data and pharmaceutical-grade formulation standards.
Male & female formulations targeting cellular senescence, inflammaging and mitochondrial dysfunction. Validated efficacy superior to traditional longevity nutraceuticals.
Post-exercise recovery and muscle repair support. Human skeletal muscle cell models demonstrate significantly superior regeneration versus Resveratrol, Metformin, Curcumin and other established nutraceuticals.
Fast-acting localized pain and inflammation relief. Topical pDEN delivery for targeted bioactive action at the site of injury or discomfort.
Flori Science technology delivers pharmaceutical-grade science in a nutraceutical platform with high degree of stability and bioavailability — without artificial stabilizers or synthetic carriers.
pDENs exhibit superior activity over cord MSCs and traditional nutraceuticals in experimental human muscle cell models.
Flori Science's natural, plant-derived approach streamlines the path to market while maintaining pharmaceutical-grade science.
Isolation and uses of plant and mushroom-derived products as nutraceuticals, drug delivery and pharmaceuticals
Sources and formulations of plant-derived nanovesicles and products
GRAS-classified ingredients for accelerated regulatory pathways and faster market entry
FDA-compliant food supplement regulatory tracks for nutraceuticals
Strategic clinical evidence collection to support health claims and future medical applications
Medical food regulatory pathway for specialized therapeutic nutrition products (in progress)
Flori Science's natural, plant-derived approach accelerates the path to market while maintaining pharmaceutical-grade science — enabling faster entry without compromising on efficacy or safety standards.
PhD in bioinformatics and disease analysis. Lead Data Scientist at IBM Research.
Professor, Bar-Ilan University. Over 160 publications in neuromuscular diseases, exosomes and cancer.
Extensive experience in R&D, marketing and strategic positions. Serial investor in the IT industry.
Expertise in financial management and capital markets. Former VP Finance in private and public companies.
Professor, plant culture and cultivation expertise. CEO of AgriManiacs LTD
Entrepreneur, President and CTO of SBH Sciences. Co-founded 10 companies, MA USA
Professor of Neurology, Wayne State University School of Medicine, Detroit, USA
Head, Rheumatology Unit & Research Authority, Meir Medical Center
Physician of Maccabi Playtika Tel Aviv
Over 15 years of experience managing clinical trials in pharma, diagnostics, and medical devices.
Over 30 years of biotech experience. Has led FDA and CE Mark approvals and clinical trials globally.
We partner with nutraceutical companies, medical institutions, distributors, and investors who believe science should lead.